Pharmaceutical1 companies from the Chinese mainland and Taiwan convened2 for the first forum3 on cross-strait industrial cooperation on Monday in Taipei, calling for further ties to boost mutual4 development.
来自中国大陆与台湾的制药公司周一齐聚台北召开首次跨海峡工业合作论坛，双方呼吁加深联系突进共同发展。
The forum, co-organized by the Taiwan-based Institute for Biotechnology and Medicine Industry (IBMI) and China Pharmaceutical Innovation and Research Development Association, has set up a platform for pharmaceutical enterprises across the strait to deepen cooperation in new drug development and grab a larger share of the global market.
Chen Weijao, chairman of the IBMI, said Taiwan has many talents conducting clinical studies and novel drug research and development, accompanied by
rigid5 regulation of pharmaceutical standards, while the Chinese mainland has a huge potential drug market.
Drug producers in Taiwan and the mainland are complementary for potential
partnerships6 in developing
innovative7 drugs and should seek new models of industrial cooperation to
attain8 win-win outcomes, Chen added.
According to Song Ruilin, executive chairman of China Pharmaceutical Innovation and Research Development Association, 11 drug companies from the mainland will hold nearly 40 face-to-face talks with 15 pharmaceutical businesses from the island during the forum.
收听单词发音 
